Tuesday, May 3, 2016

Zomedica Pharma listed on TSX Venture

Zomedica Pharma listed on TSX Venture

May 2, 2016 by · Leave a Comment 

Tweet The shares of Zomedica Pharmaceuticals (TSX-V:ZOM), a veterinary pharmaceutical company, have been listed on TSX Venture Exchange under the symbol, ZOM. “With our shares trading on TSX-V, Zomedica has a more-efficient method for raising capital to bring our veterinarian-focused products to market while concurrently delivering liquidity for shareholders,” president and CEO, Gerald Solensky, Jr., […]

Nobilis Health launches bundled payment and technology unit

Nobilis Health launches bundled payment and technology unit

May 2, 2016 by · Leave a Comment 

Tweet Nobilis Health (NYSE MKT:HLTH; TSX:NHC) has launched a comprehensive technology platform that will develop new payment and delivery methodologies to enhance value for patients, payers, and providers across the continuum of care. The new unit will be called, Concertis, and will be headed by Marissa Arreola, a former health law partner at the firm […]

GeneNews closes note financing with Alumina

GeneNews closes note financing with Alumina

April 28, 2016 by · Leave a Comment 

Tweet GeneNews (TSX:GEN) has executed a definitive financing agreement with Alumina Partners for a second tranche of a non-brokered private placement. Under the accord, GeneNews will draw down on $10-million in structured, unsecured convertible notes, at the company’s option, in installments of $200,000 over a 24-month period. The initial draw will be limited to $200,000 […]

Novadaq posts 52% jump in Q1 revenue

Novadaq posts 52% jump in Q1 revenue

April 27, 2016 by · Leave a Comment 

Tweet Novadaq Technologies (NASDAQ:NVDQ; TSX:NDQ) has reported first quarter revenue of $17.7-million, up 52%, from $11.7-million a year ago. Total direct sales in the quarter rose by $6.1-million, or 71%, and total partnered/international sales declined by $100,000, compared with the year earlier period. The company estimates that the number of procedures performed using SPY technology systems […]

Transition Therapeutics begins Phase 2 SARM study

Transition Therapeutics begins Phase 2 SARM study

April 26, 2016 by · Leave a Comment 

Tweet Transition Therapeutics (NASDAQ:TTHI, TSX:TTH) has dosed the first patient in a Phase 2 study of selective androgen receptor modulator (SARM) drug candidate, TT701. The Phase 2 study will evaluate the efficacy and safety of TT701 in improving the symptoms of androgen deficiency, including sexual symptoms, fatigue/low vitality, and physical dysfunction in men who have […]

TearLab forecasts 25% jump in Q1 revenue

TearLab forecasts 25% jump in Q1 revenue

April 20, 2016 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) estimates revenue for the first quarter this year will be about $6.8-million, reflecting a 25% increase from the first quarter of 2015. In addition, TearLab estimates that a net total of 257 TearLab Osmolarity Systems were added in the first quarter of 2016, of which 167 were under the company’s new […]

GeneNews provides financing update

GeneNews provides financing update

April 7, 2016 by · Leave a Comment 

Tweet GeneNews (TSX:GEN) has closed the first tranche of a private placement, consisting of the issuance of approximately 5.6 million common shares at a price of 10 cents each, for gross proceeds of approximately $560,000, to be used for working capital. The company also has executed a term sheet with Alumina Partners for a second […]

Nobilis converts surgical center, completes Dallas JV

Nobilis converts surgical center, completes Dallas JV

April 7, 2016 by · Leave a Comment 

Tweet Nobilis Health (NYSE MKT:HLTH; TSX:NHC) has completed the conversion of its out-of-network ambulatory surgical center, Microsurgery Institute Dallas (MSID), into an in-network hospital outpatient department (HOPD) of a local hospital system. This model provides greater earning potential for Nobilis by allowing care to be provided to patients with in-network benefits, while not detracting from […]

Microbix validating new virology production process

Microbix validating new virology production process

April 5, 2016 by · Leave a Comment 

Tweet Microbix Biosystems (TSX:MBX) is validating a new bioreactor manufacturing platform for its world-leading line of viral and bacterial antigens and other virology products ahead of a full roll-out to customers towards the end of 2016. “Once the new platform is fully implemented, it will reduce our manufacturing costs, greatly expand our available capacity and […]

GeneNews and JTS Health in business acceleration pact

GeneNews and JTS Health in business acceleration pact

March 31, 2016 by · Leave a Comment 

Tweet GeneNews (TSX:GEN) has entered into a collaboration agreement with JTS Health Partners of Atlanta to accelerate adoption of GeneNews’ menu of proprietary cancer tests, including its lead ColonSentry blood-test for assessing an individual’s current risk for colorectal cancer. JTS, a leading national healthcare management consulting and professional services firm, will also work to maximize […]

Next Page »

Email Newsletters with Constant Contact
Google+